PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

Similar documents
PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

ZADITEN Eye Drops 1.0%

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

NEVANAC TM 0.1% Eye Drops

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

ACULAR EYE DROPS 5 mg/ml Eye Drops

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

CILOXAN TM Eye Drops 0.3%

BrinzoQuin Eye Drops 1.0%

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

APO-Latanoprost Contains the active ingredient latanoprost

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

PATIENT INFORMATION LEAFLET TEXAMER

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

VOLTAREN OPHTHA Eye Drops 0.1%

ENIDIN EYE DROPS [brimonidine tartrate]

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

PATIENT INFORMATION LEAFLET

TOBRADEX TM Eye Drops

Package leaflet: Information for the user. Carmellose sodium

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

What Maxitrol Eye Drops is used for

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

AZOPT EYE DROPS 1% What is in this leaflet. Before you use Azopt. What Azopt is used for. Brinzolamide. Consumer Medicine Information.

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

TIMALEN 0.5% eye drops

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

TENOPT timolol maleate

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

TRAVATAN Eye Drops 0.004% travoprost

CONSUMER MEDICINE INFORMATION

Fluticasone propionate, 50 mcg per spray. Please read this leaflet carefully before you use FLIXONASE ALLERGY & HAYFEVER 24 HOUR.

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

DORZOLAMIDE/ TIMOLOL SANDOZ 20/5

CILOXAN 0.3% Ear Drops

PATIENT INFORMATION LEAFLET EFFERFLU C IMMUNE BOOSTER. EFFERFLU C IMMUNE BOOSTER has not been evaluated by the Medicines Control

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

MAXIDEX Eye Drops 0.1%

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

Zovirax Ophthalmic (eye) Ointment Acyclovir

CIPROXIN HC Ear Drops

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

1 What Flixonase is and what it is used for

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5%

FIRAZYR Icatibant acetate

COSDOR. What is in this leaflet. Before you use COSDOR. What COSDOR is used for. Dorzolamide hydrochloride/timolol maleate

Do not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients.

PATIENT INFORMATION LEAFLET AMLOC RANGE

ISOPTO CARPINE Eye Drops

Package leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS. Betaxolol (as hydrochloride)

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

IOPIDINE Eye Drops 0.5% Apraclonidine hydrochloride CONSUMER MEDICINE INFORMATION

IOPIDINE Eye Drops 0.5%

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide

Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

PRESCRIBING INFORMATION

NASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate

PATIENT INFORMATION LEAFLET CARZIN XL

PATIENT INFORMATION LEAFLET DYNARB RANGE

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information

PATIENT INFORMATION LEAFLET PEPLOC RANGE

Read all of this leaflet carefully before you start using this medicine.

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

AZARGA Eye Drops Brinzolamide 10 mg/ml and timolol 5 mg/ml CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide

Before prescribing DUOTRAV Eye Drops for you, your doctor will have examined the eye and decided that DUOTRAV Eye Drops is the right medicine.

PATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

Transcription:

Page 1 of 5 SCHEDULING STATUS Schedule 2 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops Read all of this leaflet carefully because it contains important information for you. RELESTAT is available without a doctor s prescription, for you to treat a mild illness. Nevertheless you still need to use RELESTAT carefully to get the best results from it. Keep this leaflet. You may need to read it again. Do not share RELESTAT with any other person. Ask your pharmacist if you need more information or advice. You must see a doctor if you symptoms worsen or do not improve after 10 days. 1. WHAT RELESTAT CONTAINS The active substance is epinastine hydrochloride. One ml of eye drop solution contains 0,5 mg of epinastine hydrochloride. The other ingredients are benzalkonium chloride 0,01 % m/v (a preservative), disodium edetate, sodium chloride, sodium dihydrogen phosphate dehydrate and purified water. 2. WHAT RELESTAT IS USED FOR RELESTAT is an anti-allergic eye drop solution used to treat the symptoms of seasonal allergic conjunctivitis, a seasonal allergic disease affecting the eye. The main symptoms treated by RELESTAT include watery eyes and eyes or eyelids which are itchy, red or swollen. 3. BEFORE YOU USE RELESTAT Do NOT use RELESTAT If you are allergic (hypersensitive) to epinastine hydrochloride or any of the other ingredients of RELESTAT listed in section WHAT RELESTAT CONTAINS. Take special care with RELESTAT RELESTAT is a topical eye drop and should not be injected or taken orally; If you wear soft contact lenses: you must remove them before using RELESTAT eye drops. After using RELESTAT, wait at least 15 minutes before putting your lenses back in. See also Important information about some of the ingredients of RELESTAT ;

Page 2 of 5 If you have to use any other eye drops during treatment with RELESTAT: leave at least 10 minutes between putting in RELESTAT and the other drops. Pregnancy and breastfeeding RELESTAT should not be used if you are pregnant or breastfeeding your baby. It is not known whether RELESTAT passes into breast milk. If you are using RELESTAT you should not breastfeed your baby. If you are pregnant or breastfeeding your baby, please consult your doctor, pharmacist or other healthcare professional for advice before using RELESTAT. Driving and using machinery Your sight may become blurred for a short time just after using RELESTAT. You should not drive or use machines until your sight is clear again. Important information about some of the ingredients in RELESTAT RELESTAT contains a preservative, called benzalkonium chloride, which can discolour soft contact lenses and may cause eye irritation. If you wear soft contact lenses (also called hydrophilic lenses) you must remove them before using the RELESTAT eye drops. After using RELESTAT, you have to wait at least 15 minutes before putting your lenses back in. Using other medicines with RELESTAT Always tell your healthcare professional if you are taking any other medicine. (This includes complementary or traditional medicines.) 4. HOW TO USE RELESTAT Do not share medicines prescribed for you with any other person. Always use RELESTAT exactly as your doctor or pharmacist has instructed you. You should check with your doctor or pharmacist if you are unsure. RELESTAT should not be used in children below 12 years of age. If you have the impression that the effect of the RELESTAT is too strong or too weak for you, tell your doctor or pharmacist. Adults and adolescents (12 years of age and older) The usual dose of RELESTAT is 1 drop in each eye that needs treatment, twice a day, for example in the morning and in the evening.

Page 3 of 5 You should use RELESTAT every day that you experience eye symptoms during the allergy season, but not for longer than 8 weeks (see Take special care with RELESTAT). Instructions for use You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first begin to use it. Apply your eye drops in the following way: 1. Wash your hands before opening the bottle. Tilt your head back and look at the ceiling. 2. Gently pull the lower eyelid down until there is a small pocket. 3. Turn the bottle upside down and squeeze it to release one drop into each eye that needs treatment. 4. Let go of the lower lid, and close your eye for 30 seconds. To avoid contamination of the solution in the bottle, do not let the tip of the bottle touch your eye or anything else. Replace and tighten the cap straight after use. Wipe off any excess liquid form your cheek with a clean tissue. The proper application of your eye drops is very important. If you have any questions ask your doctor or pharmacist. If you use more RELESTAT than you should If you use more drops of RELESTAT than you should, it is unlikely to cause you any harm. Put your next drop(s) in at the usual time. However if you are worried, consult to your doctor or pharmacist. In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre. If you forget to use RELESTAT If you forgot a dose apply it as soon as you remember, unless it is almost time for your next dose, in which case you should miss out the forgotten dose. Then, use your next dose at the usual time and continue with your normal routine. Do not use a double dose to make up for a forgotten dose. If you stop using RELESTAT RELESTAT should be used as advised by your doctor or pharmacist. If you have any further questions on the use of RELESTAT, ask your doctor or pharmacist.

Page 4 of 5 5. POSSIBLE SIDE EFFECTS RELESTAT can have side effects. Not all side effects reported for RELESTAT are included in this leaflet. Should your general health worsen or if you experience any untoward effects while using RELESTAT, please consult your doctor, pharmacist or other healthcare professional for advice. If any of the following happens, stop using RELESTAT and tell your doctor immediately or go to the casualty department at your nearest hospital: Severe allergic (hypersensitive) reaction with symptoms such as skin rash, which can be red and itchy, swelling of the eyes, throat or face; Asthma (an allergic disease affecting the lungs that causes breathing difficulties). These are all very serious side effects. If you have them, you may have had a serious allergic reaction to RELESTAT. You may need urgent medical attention or hospitalisation. The following side effects may also occur: Frequent side effects Burning sensation or irritation of the eye (mostly mild) Less frequent side effects General side effects: Headache Swelling and irritation inside the nose, which may cause a runny or blocked nose and sneezing Sinus infection Unusual taste in your mouth Side effects affecting the eye: Red eyes Dry eyes Itchy eyes Difficulty in seeing clearly Discharge from the eyes Patients have also reported the following side effects: Increased tear production Eye pain

Page 5 of 5 If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. 6. STORING AND DISPOSING OF RELESTAT Store at or below 25 C. Do not use the eye drops more than 30 days after opening. STORE ALL MEDICINES OUT OF REACH OF CHILDREN. Do not use the medicine after the expiry date printed on the bottle and the box. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains and sewerage systems (e.g. toilets). 7. PRESENTATION OF RELESTAT 5 ml LDPE bottle with a dropper insert and a white polystyrene screw cap. 8. IDENTIFICATION OF RELESTAT RELESTAT is a clear and colourless eye drop solution in a multi-dose bottle with a screwcap. 9. REGISTRATION NUMBER 37/15.4/0691 10. NAME AND ADDRESS OF THE REGISTRATION HOLDER Allergan Pharmaceuticals (Pty) Ltd 30 New Road (entrance off Bavaria Road) Randjespark Ext. 11, Midrand, 1682 Johannesburg, Gauteng SOUTH AFRICA Telephone number: + 27 (0) 11 545 6600 11. DATE OF PUBLICATION Date of registration: 11 August 2006 Date of most recent patient information leaflet as approved by Council: 29 July 2016